Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $10.88 as of 2026-04-08, marking a 0.73% decline in its latest session. This analysis explores key technical levels, prevailing market context, and potential near-term scenarios for the biotech stock, without providing investment recommendations or price forecasts. PMN’s recent price action has been largely range-bound, with limited company-specific news driving flows as of late, leading market participants to focus on technical ma
How does currency impact ProMIS (PMN) Stock | Price at $10.88, Down 0.73% - Low Risk Entry
PMN - Stock Analysis
4211 Comments
1816 Likes
1
Giya
Daily Reader
2 hours ago
Every detail feels perfectly thought out.
👍 258
Reply
2
Ambrey
Elite Member
5 hours ago
Your brain is clearly working overtime. 🧠💨
👍 230
Reply
3
Charnai
Registered User
1 day ago
This sets a high standard.
👍 185
Reply
4
Parneet
Community Member
1 day ago
Useful analysis that balances data and interpretation.
👍 184
Reply
5
Elizardo
Insight Reader
2 days ago
Wish I had known this before. 😞
👍 266
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.